Pharma Corp

Matrix Pharma Corp is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), particularly recognized for its dominant position in the antiretroviral (ARV) segment. Following its high-profile acquisition of the API business from Viatris (formerly Mylan) in 2024, the company has significantly expanded its portfolio to include over 270 commercialized APIs across more than 20 therapeutic areas. Headquartered in Hyderabad, India, Matrix operates six USFDA and EU GMP-certified manufacturing sites and serves pharmaceutical partners in over 165 countries. The company also provides comprehensive CDMO services, leveraging its robust R&D capabilities and large-scale manufacturing infrastructure to support global healthcare accessibility.